Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-19

Clinical Trial Update: Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing polyethylene glycol to sennosides for opioid-induced constipation in cancer patients; study terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene Glycol (polyethylene glycol)
  • Sennosides (senna glycosides)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Constipation, Cancer | Phase 4 | Status: TERMINATED | Results posted: 2018-10-19